Titlebook: Clinical Management of Renal Tumors; Ronald M. Bukowski,Andrew C. Novick Book 2008 The Editor(s) (if applicable) and The Author(s), under

POL

書目名稱Clinical Management of Renal Tumors影響因子(影響力)




書目名稱Clinical Management of Renal Tumors影響因子(影響力)學(xué)科排名




書目名稱Clinical Management of Renal Tumors網(wǎng)絡(luò)公開度




書目名稱Clinical Management of Renal Tumors網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Clinical Management of Renal Tumors被引頻次




書目名稱Clinical Management of Renal Tumors被引頻次學(xué)科排名




書目名稱Clinical Management of Renal Tumors年度引用




書目名稱Clinical Management of Renal Tumors年度引用學(xué)科排名




書目名稱Clinical Management of Renal Tumors讀者反饋




書目名稱Clinical Management of Renal Tumors讀者反饋學(xué)科排名

BLANC

抵押貸款

Deutschen Gesellschaft für Neurochirurgierecent identification of novel clinical and pathologic prognostic factors in RCC have resulted in gradual transition from the use of solitary clinical factors, such as tumor, node, metastasis staging system, to the introduction of systems that integrate multiple validated prognostic factors. Finally

管理員

Probleme der Sch?deldachplastikors, used varying definitions, and/or treated different patient populations, and therefore, it is difficult to fully assess their value as independent prognostic indicators..In addition to these “classical” predictors, new molecular based technologies are helping to better define the biology of rena

MERIT

T-cell Unresponsiveness in Renal Cell Carcinoma Patients, Muc-1, and Her-2/neu, but also several that may be unique to RCC..–. Despite the potential for an effective immune response to RCC, it is not well developed in this patient population even after implement of various forms of immunotherapy designed to stimulate tumor immunity. The presence of an ine

Visual-Field

Visual-Field

Surveillance Strategies Following Curative Therapy for Localized Renal Cell Carcinoma,recent identification of novel clinical and pathologic prognostic factors in RCC have resulted in gradual transition from the use of solitary clinical factors, such as tumor, node, metastasis staging system, to the introduction of systems that integrate multiple validated prognostic factors. Finally

檢查

inhumane

財(cái)政

The Role of Percutaneous Imaging-Guided Biopsy in the Diagnosis and Management of Renal Masses,ary renal neoplasms from renal tumors not treated surgically, such as metastatic disease and lymphoma. Percutaneous biopsy is also used to differentiate primary neoplasms from benign renal lesions and to establish a diagnosis of renal cell carcinoma in those patients with widespread metastatic disease or with contraindications to surgery.